Literature DB >> 8376495

High-performance liquid chromatographic assay for 4-nitrophenol hydroxylation, a putative cytochrome P-4502E1 activity, in human liver microsomes.

W Tassaneeyakul1, M E Veronese, D J Birkett, J O Miners.   

Abstract

A high-performance liquid chromatographic method which measures formation of product 4-nitrocatechol (4NC) has been developed and applied to the study of human liver microsomal 4-nitrophenol (4NP) hydroxylation. Following diethyl ether extraction, 4NC and the assay internal standard (salicylamide) were separated by reversed-phase (C18) liquid chromatography. Extraction efficiencies of 4NC and internal standard were both > 90%. The assay, which has a limit of detection of 15 pmol injected (or an incubation 4NC concentration of 0.25 microM), is accurate, reproducible and straightforward. With a chromatographic time of 12 min, 40-50 samples may be analyzed per day. Rates of 4NC formation were linear with time and protein concentration to 50 min and 0.5 mg/ml, respectively. Preliminary studies of 4NP hydroxylation showed that this reaction followed single enzyme Michaelis-Menten kinetics in human liver microsomes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8376495     DOI: 10.1016/0378-4347(93)80473-h

Source DB:  PubMed          Journal:  J Chromatogr


  5 in total

1.  Cytochrome P450 isoform selectivity in human hepatic theobromine metabolism.

Authors:  S Gates; J O Miners
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

2.  Rifampicin exacerbates isoniazid-induced toxicity in human but not in rat hepatocytes in tissue-like cultures.

Authors:  C Shen; Q Meng; G Zhang; W Hu
Journal:  Br J Pharmacol       Date:  2007-12-10       Impact factor: 8.739

3.  In vitro proguanil activation to cycloguanil by human liver microsomes is mediated by CYP3A isoforms as well as by S-mephenytoin hydroxylase.

Authors:  D J Birkett; D Rees; T Andersson; F J Gonzalez; J O Miners; M E Veronese
Journal:  Br J Clin Pharmacol       Date:  1994-05       Impact factor: 4.335

4.  Evaluation of the xenobiotic biotransformation capability of six rodent hepatoma cell lines in comparison with rat hepatocytes.

Authors:  M T Donato; A M Bassi; M J Gómez-Lechón; S Penco; E Herrero; D Adamo; J V Castell; M Ferro
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-09       Impact factor: 2.416

5.  Wild-type CYP102A1 as a biocatalyst: turnover of drugs usually metabolised by human liver enzymes.

Authors:  Giovanna Di Nardo; Andrea Fantuzzi; Anastasia Sideri; Paola Panicco; Carlo Sassone; Carlo Giunta; Gianfranco Gilardi
Journal:  J Biol Inorg Chem       Date:  2007-01-18       Impact factor: 3.862

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.